First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background: Malaria in pregnancy has major impacts on mother and child health. To complement existing interventions, such as intermittent preventive treatment and use of impregnated bed nets, we developed a malaria vaccine candidate with the aim of reducing sequestration of asexual “blood-stage” parasites in the placenta, the major virulence mechanism. Methods: The vaccine candidate PAMVAC is based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA). Healthy, adult malaria-naive volunteers were immunized with 3 intramuscular injections of 20 μg (n = 9) or 50 μg (n = 27) PAMVAC, adjuvanted with Alhydrogel or glucopyranosyl lipid adjuvant in stable emulsion (GLA-SE) or in a liposomal formulation with QS21 (GLA-LSQ). Allocation was random and double blind. The vaccine was given every 4 weeks. Volunteers were observed for 6 months following last immunization. Results: All PAMVAC formulations were safe and well tolerated. A total of 262 adverse events (AEs) occurred, 94 (10 grade 2 and 2 grade 3) at least possibly related to the vaccine. No serious AEs occurred. Distribution and severity of AEs were similar in all arms. PAMVAC was immunogenic in all participants. PAMVAC-specific antibody levels were highest with PAMVAC-GLA-SE. The antibodies inhibited binding of VAR2CSA expressing P. falciparum-infected erythrocytes to CSA in a standardized functional assay. Conclusions: PAMVAC formulated with Alhydrogel or GLA-based adjuvants was safe, well tolerated, and induced functionally active antibodies. Next, PAMVAC will be assessed in women before first pregnancies in an endemic area. Clinical Trials Registration: EudraCT 2015-001827-21; ClinicalTrials.gov NCT02647489.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two VAR2CSA N-terminal subunits containing the minimal CSA-binding fragment [5] have been tested in Phase I clinical trials [6,7] but did not induce strain-transcending neutralizing immunoglobulin G (IgG).”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibody to PAM1.4-like strain-transcending epitopes may fail to be induced by VAR2CSA subunit immunogens (Fig 1D), as seen in humans immunized with VAR2CSA fragments who mounted limited serum functional activity against heterologous strains [6,7].”
From A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us? (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenic basis of malaria
Miller, L. H., Baruch, D. I., Marsh, K., & Doumbo, O. K. (2002) · Nature · doi:10.1038/415673a · Cited by 1,746
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Baruch, D. I., Pasloske, B. L., Singh, H. B., Bi, X., Ma, X. C., Feldman, M., Taraschi, T. F., & Howard, R. J. (1995) · Cell · doi:10.1016/0092-8674(95)90054-3 · Cited by 1,030
Self-citationSalanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 1×
“1510 • cid 2019:69 (1 November) • Mordmüller et al form of chondroitin sulfate A (CSA) [8].”
BackgroundSelf-citationMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Bull, P. C., Lowe, B. S., Kortok, M., Molyneux, C. S., Newbold, C. I., & Marsh, K. (1998) · Nature Medicine · doi:10.1038/nm0398-358 · Cited by 645
Malaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Self-citationAntigens Induced on Erythrocytes by P. falciparum : Expression of Diverse and Conserved Determinants
Marsh, K., & Howard, R. J. (1986) · Science · doi:10.1126/science.2417315 · Cited by 322
Self-citationRicke, C. H., Staalsoe, T., Koram, K., Akanmori, B. D., Riley, E. M., Theander, T. G., & Hviid, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3309 · Cited by 303
Self-citation
Cited by
Items 101–175 of 175
Progress towards vaccines to protect pregnant women from malaria
Rogerson, S. J., & Aitken, E. H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.042 · Cited by 4
Tornyigah, B. (2019) · theses.fr (ABES) · doi:10.70675/2ce1dee6z72b1z4b64za51cz3eacac7fb2fa · Cited by 4
dos Santos, M. I., Dombrowski, J. G., Hoffmann-Veltung, H., Quintana, M. D. P., Marinho, C. R. F., Hviid, L., & Lopez-Perez, M. (2025) · Infection and Immunity · doi:10.1128/iai.00516-25 · Cited by 3
Hoffmann-Veltung, H., Anabire, N. G., Ofori, M. F., Janhmatz, P., Ahlborg, N., Hviid, L., & Quintana, M. D. P. (2022) · eLife · doi:10.7554/elife.79245 · Cited by 3
Extraction and Immunoprecipitation of VAR2CSA, the PfEMP1 Associated with Placental Malaria
Gamain, B., & Dorin, D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_19 · Cited by 3
How to Accelerate Early Stage of Malaria Vaccine Development by Optimizing Functional Assays
Miura, K. (2024) · Vaccines · doi:10.3390/vaccines12060586 · Cited by 3
Ambler, A. W., Towne, F., & Brooks, B. D. (2021) · Side effects of drugs annual · doi:10.1016/bs.seda.2021.07.002 · Cited by 3
Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development
Turan, G., Boggio, M. J., Othman, A. S., Nnaemeka, V., Hill, A. V. S., & Salman, A. M. (2026) · Vaccines · doi:10.3390/vaccines14030277 · Cited by 2
mSphere of Influence: Structural Insights into the Molecular Mechanism Underlying Placental Malaria
Quintana, M. D. P. (2021) · mSphere · doi:10.1128/msphere.00391-21 · Cited by 2
Misal, S. A., Renn, J. P., Morrison, R. D., Cowles, M. V., Mahamar, A., Attaher, O., Dicko, A., Duffy, P. E., & Fried, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1704346 · Cited by 2
Duffy, P. E., Healy, S. A., Gorres, J. P., & Fried, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814582-1.00015-2 · Cited by 2
Frempong, N. A., Mama, A., Adu, B., Kusi, K. A., Ofori, M. F., Ahiabor, C., Anyan, W. K., Debrah, A. Y., Anang, A. K., Ndam, N. T., et al. (2024) · Parasite Immunology · doi:10.1111/pim.13027 · Cited by 2
Self-citationDo Antibodies to Malaria Surface Antigens Play a Role in Protecting Mothers From Maternal Anemia?
Wiebe, M., & Yanow, S. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609957 · Cited by 2
Roessner, R. A., Michelarakis, N., Gräter, F., & Aponte-Santamaria, C. A. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011726 · Cited by 2
Hu, W. J., Tao, Z., Guo, W., Ding, W., Huang, S., Li, J., Peng, H., Zeng, L., Chen, Z., Qiu, R., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012618 · Cited by 2
Antibody-Dependent THP-1 Cell-Mediated Phagocytosis of Plasmodium falciparum-Infected Erythrocytes
Kassa, M. W., Hasang, W., & Rogerson, S. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_46 · Cited by 2
Exploring the P. falciparum antigens associated with reduced risk of malaria in pregnancy
Mwai, L., Musundi, S., Waweru, H., Nagaoka, H., Limbua, P. G., Tsuboi, T., Takashima, E., Gitaka, J., & Kanoi, B. N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1622435 · Cited by 2
Tackling variants with antibodies
Aitken, E. H., & Rogerson, S. J. (2022) · eLife · doi:10.7554/elife.77751 · Cited by 2
Laurens, M. B., & Plowe, C. V. (2023) · Encyclopedia of sustainability science and technology series · doi:10.1007/978-1-0716-2463-0_536 · Cited by 2
Editorial: Immunity to Parasitic Infections in Pregnancy
Doritchamou, J., Aitken, E. H., & Luty, A. J. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.813446 · Cited by 2
Self-citationCurrent Strategies to Improve Efficiency of Recombinant Subunit Vaccines
Bahar, A. G., & İmamoğlu, E. (2023) · Journal of Infectious Diseases and Epidemiology · doi:10.23937/2474-3658/1510299 · Cited by 2
Sattler, J. M., Keiber, L., Abdelrahim, A. G., Zheng, X., Jäcklin, M., Zechel, L., Moreau, C., Steinbrück, S., Fischer, M. D., Janse, C. J., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00101-6 · Cited by 2
Immunization strategies to prevent malaria in pregnancy – a multistakeholder workshop
D’Alessio, F., Honkpéhèdji, Y. J., Sirima, S. B., Gamain, B., Morten, N., Ndam, N. T., Mordmüller, B. G., Dicko, A., Adechina, R. M., Dossou, A. D., et al. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128505 · Cited by 1
Self-citationOnwuka, A. M., Aitken, E. H., Hasang, W., Madanitsa, M., Mwapasa, V., Phiri, K. S., ter Kuile, F. O., & Rogerson, S. J. (2025) · Malaria Journal · doi:10.1186/s12936-025-05773-0 · Cited by 1
Preservation of Parasite RNA in the Field
Tornyigah, B., & Ndam, N. T. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_3 · Cited by 1
Self-citationGrewal, S., Iyamu, U., Vinals, D. F., Mitran, C. J., Hegde, N., & Yanow, S. K. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00583-1 · Cited by 1
Expression of Large Full-Length PfEMP1 Proteins in HEK293 Cells
Renn, J. P., Doritchamou, J., & Duffy, P. E. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2189-9_21 · Cited by 1
Rotich, A. K., Mbogo, K., Adamba, P., Takashima, E., Gitaka, J., & Kanoi, B. N. (2025) · Open Research Europe · doi:10.12688/openreseurope.18580.1 · Cited by 1
Preconception immunisation to prevent pregnancy-associated malaria
Yanow, S. K., & Vinals, D. F. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00405-5 · Cited by 1
A need for new tools for prevention of malaria in pregnancy
Saito, M., & McGready, R. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004729 · Cited by 1
The pregnancy-associated secretome in malaria pathogenesis and immunity during gestation
Mwai, L., Adamba, P., Mordmüller, B. G., Vatish, M., Sadovsky, Y., Gitaka, J., Kobia, F., & Kanoi, B. N. (2024) · Open Research Europe · doi:10.12688/openreseurope.18351.1 · Cited by 1
Self-citationModelling the Cost-Effectiveness of a Placental Malaria Vaccine in Sub-Saharan Africa
Chinkhumba, J., Manda‐Taylor, L., D’Alessio, F., & Madanitsa, M. (2026) · Vaccines · doi:10.3390/vaccines14050378 · Cited by 1
Developing a new anti-sporozoite malaria vaccine
Datoo, M. S. (2022) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-mpp4rx2bb · Cited by 1
Kokuhennadige, V., Gonelli, C. A., Williams, O., Esterbauer, R., Kelly, A., Hasang, W., Unger, H. W., Tesine, P., Mengi, A., Kombut, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.28.721320
Mitran, C. J. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-qs9p-em57
Beyond VAR2CSA: redefining the antigenic landscape of placental malaria vaccines
Mwai, L., Limbua, P. G., Gitaka, J., & Kanoi, B. N. (2026) · Open Research Africa · doi:10.12688/openresafrica.16523.1
Kwi, P. N., Shey, R. A., Tangan, Y. A. S., Oriero, E. C., Nchanji, G. T., Chick, J. A., Ayang, B. E., Ngomba, A. E., Moyeh, M. N., Ghogomu, S. M., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10820730/v1
Nanotechnology Based Vaccination Approach in Malarial Infection
Patel, P., Faladia, M., Shah, P., & Patel, J. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-20521-7_6
Schuerman, L., & Ockenhouse, C. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00037-2
Recent Advances in Malaria Vaccine Development
Mahanta, S. K. (2022) · Wiley eBooks · doi:10.1002/9783527830589.ch13
Chagas disease, malaria, and less common protozoan and helminth infections
John, A. R. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-79525-8.00043-3
Andemel, N., Gaoussou, S., Barry, A., Issiaka, D., Mahamar, A., Traore, M., Duffy, P. E., Dicko, A., & Fried, M. (2020) · Figshare · doi:10.6084/m9.figshare.11999133
Andemel, N., Gaoussou, S., Barry, A., Issiaka, D., Mahamar, A., Traore, M., Duffy, P. E., Dicko, A., & Fried, M. (2020) · Figshare · doi:10.6084/m9.figshare.11999139
Malaria and cancer: common features and interactions
Su, X., Stadler, R. V., Teklemichael, A. A., Xu, F., & Wu, J. (2026) · Trends in Parasitology · doi:10.1016/j.pt.2026.07.004
MALARIA VACCINE DEVELOPMENT: CHALLENGES AND PROSPECTS
Etefia, E., & Inyang-Etoh, P. C. (2024) · University therapeutic journal · doi:10.56871/utj.2024.82.25.002
Towards protective immune responses against malaria in pregnant women
Daubenberger, C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30002-5
Laurens, M. B., & Plowe, C. V. (2022) · Springer eBooks · doi:10.1007/978-1-4939-2493-6_536-3
Targeting the Duffy binding protein to develop a blood stage vaccine for Plasmodium vivax malaria
Martínez, F. J. M. (2023) · theses.fr (ABES) · doi:10.70675/b722e72azeb6bz49adz9eebz1a924ecb45cf
Host–Pathogen Interactions in Malaria: Invasion, Neutralization, and Evasion
Dickey, T. H., & Tolia, N. H. (2026) · Annual Review of Microbiology · doi:10.1146/annurev-micro-042424-032639
Ambler, A. W., & Brooks, B. D. (2022) · Side effects of drugs annual · doi:10.1016/bs.seda.2022.10.003
Preclinical Evaluation of the SMNP-Adjuvanted R21 Malaria Vaccine Across Multiple Mouse Strains
Turan, G., Fedorova, K., Hill, A. V. S., & Salman, A. M. (2026) · Vaccines · doi:10.3390/vaccines14100861
Opi, D. H., Boyle, M. J., McLean, A. R. D., Reiling, L., Chan, J.-A., Stanisic, D. I., Ura, A., Mueller, I., Fowkes, F. J. I., Rogerson, S. J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16417372
Advancing protozoan vaccine research: A review of promising candidates and emerging technologies
Subudhi, M., Suresh, A., Singh, S., Ramesh, S., & Sharma, P. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108627
Challenges For Diagnosis, Treatment And Elimination Of Malaria
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4843-1
Nanocarrier-Based Drug Delivery for Pediatric Therapeutics: A Systematic Review
Koppad, B., Rugi, S., & Laguvaram, S. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.31s.97
Caractérisation moléculaire et fonctionnelle de la pseudo-tyrosine kinase-like (pTKL) de plasmodium
Gnangnon, B. (2019) · theses.fr (ABES) · doi:10.70675/2f00041az1f53z4336zaa7bz467c1233088b
Étude du transcriptome de Plasmodium falciparum dans un contexte de paludisme cérébral
Guillochon, É. (2022) · theses.fr (ABES) · doi:10.70675/88c68727z5d26z40efza2cfz1b6aa6545a90
Gupta, Y., Prajapati, S. K., & Kushwah, R. B. S. (2025) · Infectious diseases · doi:10.5772/intechopen.1006417
Advancing Vaccine Strategies for Combatting Placental Malaria: A Path to Effective Implementation
D’Alessio, F., Kaur, M., & Madanitsa, M. (2024) · International Journal of Biomedical and Clinical Analysis · doi:10.61797/ijbca.v4i1.316
Vaccine protection of the mother, the fetus, neonates and infants
Wallace, M. L., & Rosenthal, K. S. (2024) · AIMS Allergy and Immunology · doi:10.3934/allergy.2024007
Smit, M. J. (2025) · Radboud University Press eBooks · doi:10.54195/9789465151663
Ma, R., Salinas, N. D., Orr-Gonzalez, S., Richardson, B., Ouahes, T., Torano, H., Jenkins, B. J., Dickey, T. H., Neal, J., Duan, J., et al. (2024) · doi:10.1371/journal.ppat.1011879.r003
Mkindi, C. (2019) · edoc (University of Basel) · doi:10.5451/unibas-007114598
Iyamu, U., Vinals, D. F., Tornyigah, B., Arango, E., Bhat, R., Adra, T. R., Grewal, S., Martin, K., Maestre, A., Overduin, M., et al. (2023) · doi:10.3389/fcimb.2023.1202276.s001
Raghavan, S. S. R., Dagil, R., Lopez-Perez, M., Conrad, J., Bassi, M. R., Quintana, M. D. P., Choudhary, S., Gustavsson, T., Wang, Y., Gourdon, P., et al. (2022) · doi:10.1371/journal.ppat.1010924.r001
Self-citationZhang, Y., Li, X., Wang, M., Du, B., Yuan, Y., Ou, M., & Chen, W. (2026) · Insect Science · doi:10.1111/1744-7917.70394
Antimalarial treatment efficacy and safety in pregnant women
Nambozi, M. (2019) · Institutional Repository University of Antwerp (University of Antwerp)
Takashima, E., Nagaoka, H., Correia, R., Alves, P. M., Roldão, A., Christensen, D., Guderian, J. A., Fukushima, A., Viebig, N. K., Depraetere, H., et al. (2022) · doi:10.3389/fimmu.2022.1002430.s001
Metadata
- Authors
- Mordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., Dyring, C., Calle, C. L., Knoblich, A., Ibáñez, J., Esen, M., Deloron, P., Ndam, N., Issifou, S., Houard, S., Howard, R. F., Reed, S. G., Leroy, O., Luty, A. J. F., Theander, T. G., Kremsner, P. G., Salanti, A., & Nielsen, M. A.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- Institut für Tropenmedizin, Universitätsklinikum Tübingen and Deutsches Zentrum für Infektionsforschung, Germany
- University of Copenhagen (DK)
- ExpreS2ion Biotechnologies, Horsholm, Denmark
- Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital
- ExpreS2ion Biotechnologies (Denmark) (DK)
- Sorbonne Paris Cité (FR)
- Institut de Recherche Clinique du Bénin (BJ)
- European Vaccine Initiative (DE)
- Infectious Disease Research Institute (US)
- Corresponding author
- Nielsen, Morten A
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-10
- Volume
- 69
- Issue
- 9
- Pages
- 1509-1516
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC6792113
- OpenAlex
- W2910623818
- Cited by
- 154
- References
- 39
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 21 · 2023: 17 · 2022: 27 · 2021: 38 · 2020: 21 · 2019: 8
- FWCI
- 21.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Funders
- European Union in the Seventh Framework Programme (FP7-HEALTH-2012-INNOVATION, 304815)
- German Federal Ministry of Education and Research
- Danish Advanced Technology Foundation (005-2011-1)
- Bill and Melinda Gates Foundation (42387, OPP1055855)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- malaria in pregnancy, malaria vaccine, VAR2CSA, Plasmodium falciparum, placental sequestration, chondroitin sulfate A, Alhydrogel adjuvant, vaccine safety, immunogenicity, antibody binding inhibition, malaria-naive volunteers
- MeSH terms
- Adult, Aluminum Hydroxide, Chondroitin Sulfates, Double-Blind Method, Female, Humans, Injections, Intramuscular, Liposomes, Plasmodium falciparum, Pregnancy, Malaria Vaccines, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.